Paraquat (30-70 mg/kg intraperitoneally) caused typical shaking behavi
our in rats in a dose-dependent manner. Myoclonus also appeared after
the shaking behaviour in several rats treated with the highest dose of
paraquat. Morphine (5 mg/kg intraperitoneally, 30 min. before paraqua
t) significantly reduced the frequency of shaking behaviour. The allev
iation by morphine disappeared when naloxone (1.5 mg/kg intraperitonea
lly 15 min. after morphine) was coadministered. Although there was no
histological change in brain slices of paraquat-treated rats (70 mg/kg
intraperitoneally), the fluorescein uptake into brain was increased b
y the treatment. Morphine prevented the increase of fluorescein uptake
, but naloxone failed to antagonize this effect. On the other hand, in
tracerebroventricularly administered paraquat (25.7 mug/rat) caused tr
emor in all rats, but not shaking behaviour nor myoclonus. These findi
ngs suggest that paraquat administered systemically as well as central
ly may be toxic to the brain. Although the actions of paraquat on the
brain seem to be complicated, opioid receptors may play a role in the
actions.